<HashMap><database>biostudies-literature</database><scores/><additional><submitter>An AY</submitter><funding>NIAID NIH HHS</funding><pagination>105411</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11663757</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>110</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Neonatal sepsis is a deadly disease with non-specific clinical signs, delaying diagnosis and treatment. There remains a need for early biomarkers to facilitate timely intervention. Our objective was to identify neonatal sepsis gene expression biomarkers that could predict sepsis at birth, prior to clinical presentation.&lt;h4>Methods&lt;/h4>Among 720 initially healthy full-term neonates in two hospitals (The Gambia, West Africa), we identified 21 newborns who were later hospitalized for sepsis in the first 28 days of life, split into early-onset sepsis (EOS, onset ≤7 days of life) and late-onset sepsis (LOS, onset 8-28 days of life), 12 neonates later hospitalized for localized infection without evidence of systemic involvement, and 33 matched control neonates who remained hea</pubmed_abstract><journal>EBioMedicine</journal><pubmed_title>Predictive gene expression signature diagnoses neonatal sepsis before clinical presentation.</pubmed_title><pmcid>PMC11663757</pmcid><funding_grant_id>K08 AI168487</funding_grant_id><pubmed_authors>Amenyogbe N</pubmed_authors><pubmed_authors>Matlam JP</pubmed_authors><pubmed_authors>Rao S</pubmed_authors><pubmed_authors>Martino D</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Parker EPK</pubmed_authors><pubmed_authors>Larsen K</pubmed_authors><pubmed_authors>Ford R</pubmed_authors><pubmed_authors>Burnell K</pubmed_authors><pubmed_authors>Golding CN</pubmed_authors><pubmed_authors>Dibbasey T</pubmed_authors><pubmed_authors>Ndure J</pubmed_authors><pubmed_authors>van den Biggelaar AHJ</pubmed_authors><pubmed_authors>Wariri O</pubmed_authors><pubmed_authors>Njie-Jobe J</pubmed_authors><pubmed_authors>Fatou B</pubmed_authors><pubmed_authors>Bennike TB</pubmed_authors><pubmed_authors>Vo D</pubmed_authors><pubmed_authors>Odumade OA</pubmed_authors><pubmed_authors>Ben-Othman R</pubmed_authors><pubmed_authors>Chen V</pubmed_authors><pubmed_authors>Masiria G</pubmed_authors><pubmed_authors>Dhillon BK</pubmed_authors><pubmed_authors>Kirarock W</pubmed_authors><pubmed_authors>Palma P</pubmed_authors><pubmed_authors>Diray-Arce J</pubmed_authors><pubmed_authors>He D</pubmed_authors><pubmed_authors>Ozonoff A</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Cooney M</pubmed_authors><pubmed_authors>Idoko OT</pubmed_authors><pubmed_authors>Dibassey T</pubmed_authors><pubmed_authors>Francis F</pubmed_authors><pubmed_authors>Sanchez-Schmitz G</pubmed_authors><pubmed_authors>Darboe A</pubmed_authors><pubmed_authors>Plotkin A</pubmed_authors><pubmed_authors>An AY</pubmed_authors><pubmed_authors>Sanca L</pubmed_authors><pubmed_authors>Syphurs C</pubmed_authors><pubmed_authors>van Haren SD</pubmed_authors><pubmed_authors>Imam A</pubmed_authors><pubmed_authors>Smolen KK</pubmed_authors><pubmed_authors>Checkervarty A</pubmed_authors><pubmed_authors>Kraft K</pubmed_authors><pubmed_authors>Pak J</pubmed_authors><pubmed_authors>Lee AH</pubmed_authors><pubmed_authors>Bjerregaard-Andersen M</pubmed_authors><pubmed_authors>Pettengill MA</pubmed_authors><pubmed_authors>Montante S</pubmed_authors><pubmed_authors>McEnaney K</pubmed_authors><pubmed_authors>Levy O</pubmed_authors><pubmed_authors>Blimkie TM</pubmed_authors><pubmed_authors>Karoly ME</pubmed_authors><pubmed_authors>Richmond PC</pubmed_authors><pubmed_authors>Angelidou A</pubmed_authors><pubmed_authors>A</pubmed_authors><pubmed_authors>Kollmann TR</pubmed_authors><pubmed_authors>Steen H</pubmed_authors><pubmed_authors>Strandmark J</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Pomat WS</pubmed_authors><pubmed_authors>Blimkie T</pubmed_authors><pubmed_authors>Hoch A</pubmed_authors><pubmed_authors>Acton E</pubmed_authors><pubmed_authors>M</pubmed_authors><pubmed_authors>Brook B</pubmed_authors><pubmed_authors>Cai B</pubmed_authors><pubmed_authors>Hinshaw SH</pubmed_authors><pubmed_authors>Marchant A</pubmed_authors><pubmed_authors>Lasky-Su J</pubmed_authors><pubmed_authors>Vignolo S</pubmed_authors><pubmed_authors>Schaltz-Buchholzer F</pubmed_authors><pubmed_authors>Kampmann B</pubmed_authors><pubmed_authors>Falsafi R</pubmed_authors><pubmed_authors>Saleu G</pubmed_authors><pubmed_authors>Tebbutt SJ</pubmed_authors><pubmed_authors>EPIC Consortium</pubmed_authors><pubmed_authors>Shannon CP</pubmed_authors><pubmed_authors>Bennike T</pubmed_authors><pubmed_authors>Harbeson DJ</pubmed_authors><pubmed_authors>Bao W</pubmed_authors><pubmed_authors>Singh A</pubmed_authors><pubmed_authors>Malek M</pubmed_authors><pubmed_authors>Roberts E</pubmed_authors><pubmed_authors>Smith M</pubmed_authors><pubmed_authors>Hancock REW</pubmed_authors><pubmed_authors>Varankovich N</pubmed_authors><pubmed_authors>McLoughlin C</pubmed_authors><pubmed_authors>Liu A</pubmed_authors><pubmed_authors>Martino DJ</pubmed_authors><pubmed_authors>Nguyen A</pubmed_authors><pubmed_authors>Morrocchi E</pubmed_authors><pubmed_authors>Brinkman RR</pubmed_authors><pubmed_authors>Cox M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predictive gene expression signature diagnoses neonatal sepsis before clinical presentation.</name><description>&lt;h4>Background&lt;/h4>Neonatal sepsis is a deadly disease with non-specific clinical signs, delaying diagnosis and treatment. There remains a need for early biomarkers to facilitate timely intervention. Our objective was to identify neonatal sepsis gene expression biomarkers that could predict sepsis at birth, prior to clinical presentation.&lt;h4>Methods&lt;/h4>Among 720 initially healthy full-term neonates in two hospitals (The Gambia, West Africa), we identified 21 newborns who were later hospitalized for sepsis in the first 28 days of life, split into early-onset sepsis (EOS, onset ≤7 days of life) and late-onset sepsis (LOS, onset 8-28 days of life), 12 neonates later hospitalized for localized infection without evidence of systemic involvement, and 33 matched control neonates who remained hea</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-04-08T19:49:03.178Z</modification><creation>2025-04-03T23:14:04.174Z</creation></dates><accession>S-EPMC11663757</accession><cross_references><pubmed>39472236</pubmed><doi>10.1016/j.ebiom.2024.105411</doi></cross_references></HashMap>